Sun et al. (2012) PcarnBase: development of a transcriptomic database for the brain coral Platygyra carnosus. Mar Biotech doi:10.1007/s10126-012-9482-z
ESM 2.242 KEGG pathways in the transcriptome of Platygyra carnosus.
No. / Pathway / ESTs matched (percentage) / Pathway ID1 / Metabolic pathways / 5178 (13.12%) / ko01100
2 / Regulation of actin cytoskeleton / 1937 (4.91%) / ko04810
3 / Vascular smooth muscle contraction / 1887 (4.78%) / ko04270
4 / RNA transport / 1723 (4.37%) / ko03013
5 / Pathways in cancer / 1497 (3.79%) / ko05200
6 / Dilated cardiomyopathy / 1454 (3.68%) / ko05414
7 / Focal adhesion / 1429 (3.62%) / ko04510
8 / Hypertrophic cardiomyopathy (HCM) / 1426 (3.61%) / ko05410
9 / Spliceosome / 1326 (3.36%) / ko03040
10 / Tight junction / 1313 (3.33%) / ko04530
11 / Huntington's disease / 1262 (3.2%) / ko05016
12 / MAPK signaling pathway / 1223 (3.1%) / ko04010
13 / mRNA surveillance pathway / 1211 (3.07%) / ko03015
14 / Viral myocarditis / 1176 (2.98%) / ko05416
15 / Calcium signaling pathway / 1142 (2.89%) / ko04020
16 / Cardiac muscle contraction / 1098 (2.78%) / ko04260
17 / Ubiquitin mediated proteolysis / 1095 (2.78%) / ko04120
18 / Protein processing in endoplasmic reticulum / 1073 (2.72%) / ko04141
19 / Tuberculosis / 1069 (2.71%) / ko05152
20 / Endocytosis / 1022 (2.59%) / ko04144
21 / Purine metabolism / 977 (2.48%) / ko00230
22 / Amoebiasis / 970 (2.46%) / ko05146
23 / Phagosome / 907 (2.3%) / ko04145
24 / ECM-receptor interaction / 871 (2.21%) / ko04512
25 / Insulin signaling pathway / 860 (2.18%) / ko04910
26 / Neurotrophin signaling pathway / 855 (2.17%) / ko04722
27 / Lysosome / 795 (2.01%) / ko04142
28 / Oocyte meiosis / 777 (1.97%) / ko04114
29 / Salivary secretion / 769 (1.95%) / ko04970
30 / Influenza A / 761 (1.93%) / ko05164
31 / Alzheimer's disease / 750 (1.9%) / ko05010
32 / Protein digestion and absorption / 720 (1.82%) / ko04974
33 / Amyotrophic lateral sclerosis (ALS) / 716 (1.81%) / ko05014
34 / Vibrio cholerae infection / 694 (1.76%) / ko05110
35 / Cell cycle / 689 (1.75%) / ko04110
36 / Wnt signaling pathway / 672 (1.7%) / ko04310
37 / Adherens junction / 661 (1.68%) / ko04520
38 / Toxoplasmosis / 651 (1.65%) / ko05145
39 / Gastric acid secretion / 636 (1.61%) / ko04971
40 / Lysine degradation / 634 (1.61%) / ko00310
41 / GnRH signaling pathway / 634 (1.61%) / ko04912
42 / Pathogenic Escherichia coli infection / 625 (1.58%) / ko05130
43 / Shigellosis / 604 (1.53%) / ko05131
44 / Long-term potentiation / 603 (1.53%) / ko04720
45 / Fc gamma R-mediated phagocytosis / 596 (1.51%) / ko04666
46 / Olfactory transduction / 580 (1.47%) / ko04740
47 / Chemokine signaling pathway / 557 (1.41%) / ko04062
48 / Melanogenesis / 540 (1.37%) / ko04916
49 / Pyrimidine metabolism / 535 (1.36%) / ko00240
50 / Ribosome biogenesis in eukaryotes / 531 (1.35%) / ko03008
51 / Bile secretion / 524 (1.33%) / ko04976
52 / Phosphatidylinositol signaling system / 523 (1.33%) / ko04070
53 / Small cell lung cancer / 523 (1.33%) / ko05222
54 / Peroxisome / 514 (1.3%) / ko04146
55 / Progesterone-mediated oocyte maturation / 499 (1.26%) / ko04914
56 / RNA degradation / 498 (1.26%) / ko03018
57 / Starch and sucrose metabolism / 495 (1.25%) / ko00500
58 / Axon guidance / 472 (1.2%) / ko04360
59 / Prion diseases / 469 (1.19%) / ko05020
60 / Gap junction / 467 (1.18%) / ko04540
61 / Pertussis / 466 (1.18%) / ko05133
62 / Carbohydrate digestion and absorption / 465 (1.18%) / ko04973
63 / Cholinergic synapse / 454 (1.15%) / ko04725
64 / Bacterial invasion of epithelial cells / 450 (1.14%) / ko05100
65 / Measles / 448 (1.14%) / ko05162
66 / Galactose metabolism / 440 (1.12%) / ko00052
67 / Vasopressin-regulated water reabsorption / 438 (1.11%) / ko04962
68 / ABC transporters / 436 (1.1%) / ko02010
69 / Pancreatic secretion / 435 (1.1%) / ko04972
70 / Neuroactive ligand-receptor interaction / 421 (1.07%) / ko04080
71 / Leukocyte transendothelial migration / 419 (1.06%) / ko04670
72 / Phototransduction / 417 (1.06%) / ko04744
73 / Glioma / 415 (1.05%) / ko05214
74 / Glutamatergic synapse / 414 (1.05%) / ko04724
75 / Phototransduction - fly / 403 (1.02%) / ko04745
76 / Arrhythmogenic right ventricular cardiomyopathy (ARVC) / 390 (0.99%) / ko05412
77 / Prostate cancer / 375 (0.95%) / ko05215
78 / Mineral absorption / 371 (0.94%) / ko04978
79 / Arginine and proline metabolism / 371 (0.94%) / ko00330
80 / Dorso-ventral axis formation / 358 (0.91%) / ko04320
81 / TGF-beta signaling pathway / 354 (0.9%) / ko04350
82 / Basal transcription factors / 352 (0.89%) / ko03022
83 / Long-term depression / 349 (0.88%) / ko04730
84 / NOD-like receptor signaling pathway / 345 (0.87%) / ko04621
85 / p53 signaling pathway / 344 (0.87%) / ko04115
86 / Hepatitis C / 339 (0.86%) / ko05160
87 / Osteoclast differentiation / 337 (0.85%) / ko04380
88 / ErbB signaling pathway / 336 (0.85%) / ko04012
89 / Notch signaling pathway / 336 (0.85%) / ko04330
90 / Cell adhesion molecules (CAMs) / 335 (0.85%) / ko04514
91 / Apoptosis / 334 (0.85%) / ko04210
92 / Parkinson's disease / 329 (0.83%) / ko05012
93 / PPAR signaling pathway / 313 (0.79%) / ko03320
94 / Glycerophospholipid metabolism / 312 (0.79%) / ko00564
95 / Ribosome / 299 (0.76%) / ko03010
96 / Glycolysis / Gluconeogenesis / 299 (0.76%) / ko00010
97 / Valine, leucine and isoleucine degradation / 292 (0.74%) / ko00280
98 / T cell receptor signaling pathway / 289 (0.73%) / ko04660
99 / Chagas disease (American trypanosomiasis) / 286 (0.72%) / ko05142
100 / Toll-like receptor signaling pathway / 285 (0.72%) / ko04620
101 / Pyruvate metabolism / 284 (0.72%) / ko00620
102 / RIG-I-like receptor signaling pathway / 280 (0.71%) / ko04622
103 / Adipocytokine signaling pathway / 277 (0.7%) / ko04920
104 / Bladder cancer / 272 (0.69%) / ko05219
105 / Inositol phosphate metabolism / 270 (0.68%) / ko00562
106 / Tryptophan metabolism / 263 (0.67%) / ko00380
107 / Glycine, serine and threonine metabolism / 262 (0.66%) / ko00260
108 / B cell receptor signaling pathway / 259 (0.66%) / ko04662
109 / mTOR signaling pathway / 258 (0.65%) / ko04150
110 / Endocrine and other factor-regulated calcium reabsorption / 255 (0.65%) / ko04961
111 / RNA polymerase / 253 (0.64%) / ko03020
112 / Oxidative phosphorylation / 252 (0.64%) / ko00190
113 / Antigen processing and presentation / 252 (0.64%) / ko04612
114 / Fatty acid metabolism / 251 (0.64%) / ko00071
115 / Renal cell carcinoma / 249 (0.63%) / ko05211
116 / VEGF signaling pathway / 249 (0.63%) / ko04370
117 / Tyrosine metabolism / 244 (0.62%) / ko00350
118 / Drug metabolism - other enzymes / 243 (0.62%) / ko00983
119 / Hedgehog signaling pathway / 243 (0.62%) / ko04340
120 / Propanoate metabolism / 242 (0.61%) / ko00640
121 / Vitamin digestion and absorption / 242 (0.61%) / ko04977
122 / Glutathione metabolism / 242 (0.61%) / ko00480
123 / Type II diabetes mellitus / 241 (0.61%) / ko04930
124 / Glycerolipid metabolism / 239 (0.61%) / ko00561
125 / Amino sugar and nucleotide sugar metabolism / 237 (0.6%) / ko00520
126 / Nucleotide excision repair / 237 (0.6%) / ko03420
127 / Retinol metabolism / 234 (0.59%) / ko00830
128 / Cysteine and methionine metabolism / 218 (0.55%) / ko00270
129 / Leishmaniasis / 216 (0.55%) / ko05140
130 / Staphylococcus aureus infection / 216 (0.55%) / ko05150
131 / Fc epsilon RI signaling pathway / 214 (0.54%) / ko04664
132 / Arachidonic acid metabolism / 213 (0.54%) / ko00590
133 / Drug metabolism - cytochrome P450 / 212 (0.54%) / ko00982
134 / Complement and coagulation cascades / 212 (0.54%) / ko04610
135 / Epithelial cell signaling in Helicobacter pylori infection / 210 (0.53%) / ko05120
136 / Chronic myeloid leukemia / 207 (0.52%) / ko05220
137 / Cytokine-cytokine receptor interaction / 206 (0.52%) / ko04060
138 / Pentose and glucuronate interconversions / 203 (0.51%) / ko00040
139 / Taste transduction / 202 (0.51%) / ko04742
140 / Malaria / 198 (0.5%) / ko05144
141 / Fructose and mannose metabolism / 196 (0.5%) / ko00051
142 / Endometrial cancer / 195 (0.49%) / ko05213
143 / Thyroid cancer / 195 (0.49%) / ko05216
144 / beta-Alanine metabolism / 194 (0.49%) / ko00410
145 / Steroid hormone biosynthesis / 194 (0.49%) / ko00140
146 / Natural killer cell mediated cytotoxicity / 193 (0.49%) / ko04650
147 / Citrate cycle (TCA cycle) / 188 (0.48%) / ko00020
148 / Rheumatoid arthritis / 188 (0.48%) / ko05323
149 / Metabolism of xenobiotics by cytochrome P450 / 187 (0.47%) / ko00980
150 / Colorectal cancer / 187 (0.47%) / ko05210
151 / N-Glycan biosynthesis / 183 (0.46%) / ko00510
152 / Butanoate metabolism / 183 (0.46%) / ko00650
153 / Fat digestion and absorption / 181 (0.46%) / ko04975
154 / Aminoacyl-tRNA biosynthesis / 173 (0.44%) / ko00970
155 / Base excision repair / 172 (0.44%) / ko03410
156 / Homologous recombination / 172 (0.44%) / ko03440
157 / Jak-STAT signaling pathway / 171 (0.43%) / ko04630
158 / Other types of O-glycan biosynthesis / 169 (0.43%) / ko00514
159 / Non-small cell lung cancer / 168 (0.43%) / ko05223
160 / Systemic lupus erythematosus / 167 (0.42%) / ko05322
161 / Basal cell carcinoma / 167 (0.42%) / ko05217
162 / Pancreatic cancer / 166 (0.42%) / ko05212
163 / DNA replication / 165 (0.42%) / ko03030
164 / Cytosolic DNA-sensing pathway / 164 (0.42%) / ko04623
165 / Alanine, aspartate and glutamate metabolism / 164 (0.42%) / ko00250
166 / Fatty acid biosynthesis / 160 (0.41%) / ko00061
167 / Aldosterone-regulated sodium reabsorption / 149 (0.38%) / ko04960
168 / Biosynthesis of unsaturated fatty acids / 146 (0.37%) / ko01040
169 / African trypanosomiasis / 143 (0.36%) / ko05143
170 / Melanoma / 142 (0.36%) / ko05218
171 / Histidine metabolism / 141 (0.36%) / ko00340
172 / Acute myeloid leukemia / 141 (0.36%) / ko05221
173 / Porphyrin and chlorophyll metabolism / 137 (0.35%) / ko00860
174 / Sphingolipid metabolism / 136 (0.34%) / ko00600
175 / Hematopoietic cell lineage / 136 (0.34%) / ko04640
176 / Linoleic acid metabolism / 128 (0.32%) / ko00591
177 / Proteasome / 126 (0.32%) / ko03050
178 / Glycosaminoglycan degradation / 119 (0.3%) / ko00531
179 / alpha-Linolenic acid metabolism / 119 (0.3%) / ko00592
180 / Glycosaminoglycan biosynthesis - heparan sulfate / 119 (0.3%) / ko00534
181 / Phenylalanine metabolism / 119 (0.3%) / ko00360
182 / Ether lipid metabolism / 118 (0.3%) / ko00565
183 / Mismatch repair / 115 (0.29%) / ko03430
184 / Pentose phosphate pathway / 114 (0.29%) / ko00030
185 / Protein export / 113 (0.29%) / ko03060
186 / Ascorbate and aldarate metabolism / 113 (0.29%) / ko00053
187 / Nicotinate and nicotinamide metabolism / 104 (0.26%) / ko00760
188 / Nitrogen metabolism / 103 (0.26%) / ko00910
189 / Regulation of autophagy / 97 (0.25%) / ko04140
190 / One carbon pool by folate / 97 (0.25%) / ko00670
191 / Circadian rhythm - mammal / 92 (0.23%) / ko04710
192 / Other glycan degradation / 88 (0.22%) / ko00511
193 / Glyoxylate and dicarboxylate metabolism / 87 (0.22%) / ko00630
194 / Riboflavin metabolism / 83 (0.21%) / ko00740
195 / Pantothenate and CoA biosynthesis / 81 (0.21%) / ko00770
196 / Selenocompound metabolism / 80 (0.2%) / ko00450
197 / Non-homologous end-joining / 80 (0.2%) / ko03450
198 / Proximal tubule bicarbonate reclamation / 78 (0.2%) / ko04964
199 / Cyanoamino acid metabolism / 78 (0.2%) / ko00460
200 / SNARE interactions in vesicular transport / 76 (0.19%) / ko04130
201 / Steroid biosynthesis / 75 (0.19%) / ko00100
202 / Circadian rhythm - fly / 75 (0.19%) / ko04711
203 / MAPK signaling pathway - fly / 75 (0.19%) / ko04013
204 / Primary immunodeficiency / 74 (0.19%) / ko05340
205 / Collecting duct acid secretion / 74 (0.19%) / ko04966
206 / Primary bile acid biosynthesis / 71 (0.18%) / ko00120
207 / Glycosylphosphatidylinositol(GPI)-anchor biosynthesis / 71 (0.18%) / ko00563
208 / Fatty acid elongation / 67 (0.17%) / ko00062
209 / Folate biosynthesis / 66 (0.17%) / ko00790
210 / Glycosaminoglycan biosynthesis - chondroitin sulfate / 62 (0.16%) / ko00532
211 / Sulfur metabolism / 56 (0.14%) / ko00920
212 / Autoimmune thyroid disease / 55 (0.14%) / ko05320
213 / Ubiquinone and other terpenoid-quinone biosynthesis / 54 (0.14%) / ko00130
214 / Valine, leucine and isoleucine biosynthesis / 53 (0.13%) / ko00290
215 / Taurine and hypotaurine metabolism / 52 (0.13%) / ko00430
216 / Terpenoid backbone biosynthesis / 52 (0.13%) / ko00900
217 / Maturity onset diabetes of the young / 51 (0.13%) / ko04950
218 / Renin-angiotensin system / 51 (0.13%) / ko04614
219 / Mucin type O-Glycan biosynthesis / 49 (0.12%) / ko00512
220 / Glycosphingolipid biosynthesis - ganglio series / 47 (0.12%) / ko00604
221 / Glycosphingolipid biosynthesis - globo series / 45 (0.11%) / ko00603
222 / Sulfur relay system / 43 (0.11%) / ko04122
223 / D-Arginine and D-ornithine metabolism / 41 (0.1%) / ko00472
224 / Type I diabetes mellitus / 36 (0.09%) / ko04940
225 / Synthesis and degradation of ketone bodies / 36 (0.09%) / ko00072
226 / Phenylalanine, tyrosine and tryptophan biosynthesis / 33 (0.08%) / ko00400
227 / Caffeine metabolism / 32 (0.08%) / ko00232
228 / Lysine biosynthesis / 31 (0.08%) / ko00300
229 / Glycosaminoglycan biosynthesis - keratan sulfate / 25 (0.06%) / ko00533
230 / Glycosphingolipid biosynthesis - lacto and neolacto series / 23 (0.06%) / ko00601
231 / Insect hormone biosynthesis / 22 (0.06%) / ko00981
232 / Vitamin B6 metabolism / 22 (0.06%) / ko00750
233 / Thiamine metabolism / 17 (0.04%) / ko00730
234 / D-Glutamine and D-glutamate metabolism / 16 (0.04%) / ko00471
235 / Allograft rejection / 12 (0.03%) / ko05330
236 / Lipoic acid metabolism / 10 (0.03%) / ko00785
237 / Graft-versus-host disease / 10 (0.03%) / ko05332
238 / Biotin metabolism / 9 (0.02%) / ko00780
239 / Polyketide sugar unit biosynthesis / 5 (0.01%) / ko00523
240 / Asthma / 2 (0.01%) / ko05310
241 / Butirosin and neomycin biosynthesis / 2 (0.01%) / ko00524
242 / Intestinal immune network for IgA production / 1 (0%) / ko04672
1